Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30906
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHicks, Amelia J-
dc.contributor.authorPonsford, Jennie L-
dc.contributor.authorSpitz, Gershon-
dc.contributor.authorDoré, Vincent-
dc.contributor.authorKrishnadas, Natasha-
dc.contributor.authorRoberts, Caroline-
dc.contributor.authorRowe, Christopher C-
dc.date2022-
dc.date.accessioned2022-09-20T06:51:59Z-
dc.date.available2022-09-20T06:51:59Z-
dc.date.issued2022-09-13-
dc.identifier.citationNeurology 2022; 99(11): e1131-e1141en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30906-
dc.description.abstractTraumatic brain injury (TBI) has been promoted as a risk factor for Alzheimer disease (AD). There is evidence of elevated β-amyloid (Aβ) and tau, the pathologic hallmarks of AD, immediately following TBI. It is not clear whether Aβ and tau remain elevated in the chronic period. To address this issue, we assessed Aβ and tau burden in long-term TBI survivors and healthy controls using PET imaging. Using a cross-sectional design, we recruited individuals following a single moderate to severe TBI at least 10 years previously from an inpatient rehabilitation program. A demographically similar healthy control group was recruited from the community. PET data were acquired using 18F-NAV4694 (Aβ) and 18F-MK6240 (tau) tracers. Aβ deposition was quantified using the Centiloid scale. Tau deposition was quantified using the standardized uptake value ratio (SUVR) in 4 regions of interest (ROIs). As a secondary measure, PET scans were also visually read as positive or negative. We examined PET data in relation to time since injury and age at injury. PET data were analyzed in a series of regression analyses. The sample comprised 87 individuals with TBI (71.3% male; 28.7% female; mean 57.53 years, SD 11.53) and 59 controls (59.3% male; 40.7% female; mean 60.34 years, SD 11.97). Individuals with TBI did not have significantly higher 18F-NAV4694 Centiloid values (p = 0.067) or 18F-MK6240 tau SUVRs in any ROI (p ≤ 0.001; SUVR greater for controls). Visual assessment was consistent with the quantification; individuals with TBI were not more likely than controls to have a positive Aβ (p = 0.505) or tau scan (p = 0.221). No associations were identified for Aβ or tau burden with time since injury (p = 0.057 to 0.332) or age at injury. A single moderate to severe TBI was not associated with higher burden of Aβ or tau pathologies in the chronic period relative to healthy controls. Aβ and tau burden did not show a significant increase with years since injury, and burden did not appear to be greater for those who were older at the time of injury.en_US
dc.language.isoeng
dc.titleβ-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury: A Cross-sectional Study.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleNeurologyen_US
dc.identifier.affiliationMonash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.)en_US
dc.identifier.affiliationTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Claytonen_US
dc.identifier.affiliationMolecular Imaging and Therapyen_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationUniversity of Melbourneen_US
dc.identifier.affiliationand CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australiaen_US
dc.identifier.doi10.1212/WNL.0000000000200857en_US
dc.type.contentTexten_US
dc.identifier.orcidhttps://orcid.org/0000-0002-1152-0576en_US
dc.identifier.orcidhttps://orcid.org/0000-0003-0430-125Xen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-7810-1480en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-8051-0558en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-5374-2839en_US
dc.identifier.orcidhttps://orcid.org/0000-0003-3910-2453en_US
dc.identifier.pubmedid36096678
local.name.researcherDoré, Vincent
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

50
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.